The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TRULICITY 4.5 MG/0.5 ML PEN 0.5ML pharmaceuticals. The contract has a completion date of January 29, 2024 and a potential value of $7,850.12. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors listed. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025, which serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract does not have a set-aside designation.
Generated 4/26/24, 9:15 AM